Table 3.
Characteristics | Intention-to-Treat | Per Protocol (≥ 80% adherence) | ||||
---|---|---|---|---|---|---|
Aerobic (n = 58) |
Control (n = 67) |
p-value | Aerobic (n = 30) |
Control (n = 67) |
p-value | |
Sex | ||||||
Male (n)c | 50.0% [29] | 45.6% [31] | 0.68 | 50.0% [15] | 45.6% [31] | 0.83 |
Length of Gestation (weeks)b | 39.6 (30.5, 41.9) | 39.3 (23.7, 41.3) | 0.53 | 39.7 (34.0, 41.9) | 39.3 (23.7, 41.3) | 0.39 |
Preterm (n)c | 13.8% [8] | 12.1 | 1.00 | 13.3 | 12.1 | 1.00 |
Size at Birth | ||||||
Birthweight (kg)a | 3.4 (0.7) | 3.3 (0.6) | 0.63 | 3.3 (0.7) | 3.3 (0.6) | 0.96 |
Low Birthweight (n)c | 13.8% [8] | 9.0% [6] | 0.49 | 13.8% [8] | 9.0% [6] | 0.49 |
Birth Length (m)b | 0.50 (0.35, 0.56) | 0.50 (44.5, 0.54) | 0.46 | 0.49 (0.35, 0.53) | 0.50 (44.5, 0.54) | 0.45 |
Head Circumference (cm)b | 34.5 (26.0, 38.1) | 33.7 (28.0, 45.0) | 0.32 | 34.5 (28.5, 38.1) | 33.7 (28.0, 45.0) | 0.46 |
Abdominal Circumference (cm)b | 31.5 (23.5, 35.6) | 31.0 (22.0, 37.5) | 0.49 | 31.1 (23.5, 35.6) | 31.0 (22.0, 37.5) | 0.78 |
Note: Means (SD), medians (range), and proportions are reported and astudent’s t-test, bWilcoxon Rank Sum, cFisher’s exact tests were performed, respectively